HemACTIVE is a global research survey in which Bayer is engaging people living with hemophilia A between the ages of 18-65 years and parents of children ages 2-18 years old living with the disease from North America and Europe. The survey aims to identify how hemophilia A affects the daily lives of persons living with this chronic disease and to better understand the role of treatment. To date, over 300 persons with hemophilia have participated and helped to generate great insights on the impact of hemophilia A on many facets of life, including how they define activity.

Kantar Health, a market research firm specializing in medical research, is currently recruiting people living with hemophilia A to take part in the online survey.

Potential participants must meet the following criteria:
• At least 18 years of age
• Diagnosed with moderate or severe hemophilia A (or caregiver of a child diagnosed with moderate or severe hemophilia A)
• Not currently diagnosed with clinically significant inhibitors
• Currently manage their condition with prophylaxis or on demand treatment

In order to participate in the survey, please visit: https://surveys.globaltestmarket.com/…/…/bmr/v3/91226529/LP…

The survey will take approximately 25 minutes to complete online. Participation is strictly voluntary and there are no right or wrong answers. All participants who complete the survey will receive compensation of $92.00 by mailed check. Please note that all responses will be kept strictly confidential and will be presented in aggregate with those of other participants.